Thailand · Delayed Price · Currency is THB BKK:KLINIQ Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 6.11 billion. The enterprise value is 5.84 billion.
| Market Cap | 6.11B |
| Enterprise Value | 5.84B |
Important Dates
The next estimated earnings date is Thursday, May 21, 2026.
| Earnings Date | May 21, 2026 |
| Ex-Dividend Date | Apr 29, 2026 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 65.87% |
| Owned by Institutions (%) | 0.82% |
| Float | 73.90M |
Valuation Ratios
The trailing PE ratio is 15.31 and the forward PE ratio is 15.47. BKK:KLINIQ's PEG ratio is 1.17.
| PE Ratio | 15.31 |
| Forward PE | 15.47 |
| PS Ratio | 1.59 |
| PB Ratio | 3.21 |
| P/TBV Ratio | 3.23 |
| P/FCF Ratio | 13.85 |
| P/OCF Ratio | 8.25 |
| PEG Ratio | 1.17 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.70, with an EV/FCF ratio of 13.25.
| EV / Earnings | 14.60 |
| EV / Sales | 1.53 |
| EV / EBITDA | 6.70 |
| EV / EBIT | 11.08 |
| EV / FCF | 13.25 |
Financial Position
The company has a current ratio of 1.27, with a Debt / Equity ratio of 0.34.
| Current Ratio | 1.27 |
| Quick Ratio | 0.82 |
| Debt / Equity | 0.34 |
| Debt / EBITDA | 0.78 |
| Debt / FCF | 1.49 |
| Interest Coverage | 19.54 |
Financial Efficiency
Return on equity (ROE) is 22.13% and return on invested capital (ROIC) is 24.59%.
| Return on Equity (ROE) | 22.13% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 24.59% |
| Return on Capital Employed (ROCE) | 21.91% |
| Weighted Average Cost of Capital (WACC) | 5.98% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 526 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BKK:KLINIQ has paid 108.97 million in taxes.
| Income Tax | 108.97M |
| Effective Tax Rate | 21.39% |
Stock Price Statistics
The stock price has increased by +25.00% in the last 52 weeks. The beta is 0.37, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | 0.37 |
| 52-Week Price Change | +25.00% |
| 50-Day Moving Average | 25.78 |
| 200-Day Moving Average | 24.64 |
| Relative Strength Index (RSI) | 57.67 |
| Average Volume (20 Days) | 372,291 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 3.83 billion and earned 400.03 million in profits. Earnings per share was 1.82.
| Revenue | 3.83B |
| Gross Profit | 1.94B |
| Operating Income | 527.35M |
| Pretax Income | 509.45M |
| Net Income | 400.03M |
| EBITDA | 724.31M |
| EBIT | 527.35M |
| Earnings Per Share (EPS) | 1.82 |
Balance Sheet
The company has 927.26 million in cash and 654.84 million in debt, with a net cash position of 272.43 million or 1.24 per share.
| Cash & Cash Equivalents | 927.26M |
| Total Debt | 654.84M |
| Net Cash | 272.43M |
| Net Cash Per Share | 1.24 |
| Equity (Book Value) | 1.90B |
| Book Value Per Share | 8.61 |
| Working Capital | 311.18M |
Cash Flow
In the last 12 months, operating cash flow was 740.15 million and capital expenditures -299.25 million, giving a free cash flow of 440.90 million.
| Operating Cash Flow | 740.15M |
| Capital Expenditures | -299.25M |
| Depreciation & Amortization | 196.96M |
| Net Borrowing | -147.10M |
| Free Cash Flow | 440.90M |
| FCF Per Share | 2.00 |
Margins
Gross margin is 50.76%, with operating and profit margins of 13.77% and 10.45%.
| Gross Margin | 50.76% |
| Operating Margin | 13.77% |
| Pretax Margin | 13.31% |
| Profit Margin | 10.45% |
| EBITDA Margin | 18.92% |
| EBIT Margin | 13.77% |
| FCF Margin | 11.52% |
Dividends & Yields
This stock pays an annual dividend of 1.45, which amounts to a dividend yield of 5.32%.
| Dividend Per Share | 1.45 |
| Dividend Yield | 5.32% |
| Dividend Growth (YoY) | 3.57% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 79.74% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.32% |
| Earnings Yield | 6.55% |
| FCF Yield | 7.22% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BKK:KLINIQ has an Altman Z-Score of 3.78 and a Piotroski F-Score of 3.
| Altman Z-Score | 3.78 |
| Piotroski F-Score | 3 |